share_log

Swiss National Bank Has $1.24 Million Stock Position in Invitae Co. (NYSE:NVTA)

Swiss National Bank Has $1.24 Million Stock Position in Invitae Co. (NYSE:NVTA)

瑞士国家银行持有价值124万美元的Invitae Co.(纽约证券交易所代码:NVTA)股票
Defense World ·  2022/12/02 17:21

Swiss National Bank boosted its holdings in shares of Invitae Co. (NYSE:NVTA – Get Rating) by 5.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 506,600 shares of the medical research company's stock after buying an additional 24,900 shares during the period. Swiss National Bank owned approximately 0.22% of Invitae worth $1,236,000 as of its most recent filing with the Securities and Exchange Commission.

根据瑞士国家银行向美国证券交易委员会的最新披露,该行在第二季度增持了Invitae Co.(纽约证券交易所代码:NVTA-GET评级)股票5.2%。该公司在此期间额外购买了24,900股票后,拥有这家医学研究公司的506,600股票。截至最近提交给美国证券交易委员会的文件,瑞士国家银行拥有Invitae约0.22%的股份,价值1,236,000美元。

Other large investors have also recently bought and sold shares of the company. Operose Advisors LLC acquired a new position in Invitae in the 1st quarter worth about $32,000. Cetera Investment Advisers acquired a new position in Invitae in the 1st quarter worth about $82,000. SG Americas Securities LLC increased its position in Invitae by 42.1% in the 1st quarter. SG Americas Securities LLC now owns 10,341 shares of the medical research company's stock worth $82,000 after purchasing an additional 3,062 shares during the last quarter. MQS Management LLC acquired a new position in Invitae in the 2nd quarter worth about $28,000. Finally, Oppenheimer & Co. Inc. acquired a new position in Invitae in the 2nd quarter worth about $30,000. 88.27% of the stock is owned by institutional investors and hedge funds.

其他大型投资者最近也买卖了该公司的股票。Operose Advisors LLC在第一季度收购了Invitae的一个新头寸,价值约3.2万美元。Eltera Investment Advisers在第一季度收购了Invitae的一个新头寸,价值约82,000美元。第一季度,SG America Securities LLC将其在Invitae的头寸增加了42.1%。SG America Securities LLC现在持有这家医疗研究公司10,341股股票,价值82,000美元,上个季度又购买了3,062股。MQS Management LLC在第二季度收购了Invitae的一个新头寸,价值约28,000美元。最后,Oppenheimer&Co.Inc.在第二季度收购了Invitae的一个新头寸,价值约3万美元。88.27%的股票由机构投资者和对冲基金持有。

Get
到达
Invitae
邀请函
alerts:
警报:

Invitae Price Performance

Invitae性价比

Shares of NYSE:NVTA opened at $2.97 on Friday. The business has a 50 day moving average price of $2.57 and a 200 day moving average price of $2.89. Invitae Co. has a twelve month low of $1.83 and a twelve month high of $18.44. The company has a market cap of $721.40 million, a price-to-earnings ratio of -0.21 and a beta of 1.59. The company has a quick ratio of 6.18, a current ratio of 6.44 and a debt-to-equity ratio of 10.03.

纽约证券交易所股票代码:NVTA上周五开盘报2.97美元。该业务的50日移动均线价格为2.57美元,200日移动均线价格为2.89美元。Invitae Co.股价跌至1.83美元的12个月低点和18.44美元的12个月高点。该公司市值为7.214亿美元,市盈率为-0.21倍,贝塔系数为1.59。该公司的速动比率为6.18,流动比率为6.44,债务权益比为10.03。

Invitae (NYSE:NVTA – Get Rating) last announced its quarterly earnings data on Tuesday, November 8th. The medical research company reported ($0.42) EPS for the quarter, topping analysts' consensus estimates of ($0.59) by $0.17. Invitae had a negative return on equity of 39.04% and a negative net margin of 617.65%. The company had revenue of $133.54 million during the quarter, compared to the consensus estimate of $132.80 million. Research analysts predict that Invitae Co. will post -2.43 earnings per share for the current year.
Invitae(纽约证券交易所代码:NVTA-GET Rating)最近一次公布季度收益数据是在11月8日星期二。这家医疗研究公司公布了该季度每股收益(0.42美元),比分析师普遍预期的(0.59美元)高出0.17美元。Invitae的净资产回报率为负39.04%,净利润率为负617.65%。该公司本季度营收为1.3354亿美元,而市场普遍预期为1.328亿美元。研究分析师预计,Invitae Co.今年的每股收益将达到2.43美元。

Wall Street Analysts Forecast Growth

华尔街分析师预测经济增长

NVTA has been the topic of several research reports. Cowen upped their target price on Invitae to $2.80 in a research report on Tuesday, November 15th. SVB Leerink increased their price objective on Invitae from $2.50 to $3.00 and gave the company a "market perform" rating in a report on Wednesday, November 9th. StockNews.com raised Invitae to a "sell" rating in a report on Friday, November 18th. JPMorgan Chase & Co. lowered Invitae from a "neutral" rating to an "underweight" rating in a report on Wednesday, August 10th. Finally, William Blair reissued a "market perform" rating on shares of Invitae in a report on Tuesday, November 8th. Four equities research analysts have rated the stock with a sell rating and nine have assigned a hold rating to the company. Based on data from MarketBeat.com, Invitae currently has a consensus rating of "Hold" and a consensus price target of $8.04.

NVTA一直是几份研究报告的主题。考恩在11月15日周二的一份研究报告中将Invitae的目标价上调至2.80美元。SVB Leerink将Invitae的目标价从2.50美元上调至3.00美元,并在11月9日周三的一份报告中给出了该公司“市场表现”的评级。在11月18日星期五的一份报告中,StockNews.com将Invitae的评级上调至“卖出”。摩根大通公司在8月10日星期三的一份报告中将Invitae的评级从中性下调至减持。最后,威廉·布莱尔在11月8日(星期二)的一份报告中重新对Invitae的股票进行了“市场表现”评级。4名股票研究分析师对该股的评级为卖出,9名分析师对该公司的评级为持有。根据MarketBeat.com的数据,Invitae目前的共识评级为持有,共识目标价为8.04美元。

About Invitae

关于Invitae

(Get Rating)

(获取评级)

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services.

Invitae公司是一家医学遗传学公司,将遗传信息整合到主流医学中,以改善美国、加拿大和国际上人们的医疗保健。该公司提供各种临床领域的基因测试,包括遗传癌、心脏病学、神经病学、儿科、肿瘤学、代谢疾病和罕见疾病;数字健康解决方案;以及健康数据服务。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Invitae (NVTA)
  • Ford Revving Up Production Of EV Power Units At U.K. Plant
  • Are the Short Sellers Still Right About Mullen Automotive stock?
  • La-Z-Boy Reclines To More Comfortable Levels
  • Is Apple Going To Rally Into Year End?
  • Is The Recovery Rally Here For SoFi?
  • 免费获取StockNews.com关于Invitae的研究报告(NVTA)
  • 福特在英国工厂加速生产电动汽车动力装置
  • 卖空者对马伦汽车股票的看法仍然正确吗?
  • La-Z-Boy倾斜到更舒适的水平
  • 苹果会在年底前大涨吗?
  • 复苏集会是为SoFi而来的吗?

Want to see what other hedge funds are holding NVTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invitae Co. (NYSE:NVTA – Get Rating).

想看看还有哪些对冲基金持有NVTA吗?访问HoldingsChannel.com获取Invitae Co.(纽约证券交易所代码:NVTA-GET Rating)的最新13F文件和内幕交易信息。

Receive News & Ratings for Invitae Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invitae and related companies with MarketBeat.com's FREE daily email newsletter.

接受《邀请日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Invitae和相关公司的最新新闻和分析师评级的每日简要摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发